Lansoprazole Capsule, Delayed Release
Product Images NDC 31722-571

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 31722-571). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lansoprazolefigure1 (Lansoprazolefigure1)

A line graph titled 'Mean Severity of Day Heartburn By Study Day For Evaluable Patients' comparing placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD. The x-axis shows days from start of treatment (0 to 60), and the y-axis shows mean severity of day heartburn on a scale from 0 (none) to 3 (severe). The graph illustrates a decrease in heartburn severity over time for both Lansoprazole dosages compared to placebo.*

FDA Label Image

Lansoprazolefigure2 (Lansoprazolefigure2)

A line graph showing mean severity of night heartburn over 60 days from the start of treatment. The graph compares three groups: placebo, Lansoprazole 15 mg once daily, and Lansoprazole 30 mg once daily, indicating decreasing severity over time for Lansoprazole groups compared to placebo.*

FDA Label Image

Lansoprazolestructure (Lansoprazolestructure)

Chemical structure diagram of the active ingredient Lansoprazole, showing its molecular arrangement with labeled atoms and bonds representing its chemical composition.*

FDA Label Image

Camber (Camber)

FDA Label Image

Lans15mg (Lans15mg)

Label of Lansoprazole Delayed-Release Capsules, USP 15 mg by Camber Pharmaceuticals, Inc. The label shows the product name, strength, dosage form, and quantity (30 capsules). It includes storage instructions, usage warnings, and contact information. The capsules contain 15 mg of lansoprazole as enteric-coated pellets. The label also displays a barcode and manufacturer details.*

FDA Label Image

Lans30mg (Lans30mg)

Label for Lansoprazole Delayed-Release Capsules USP 30 mg by Camber Pharmaceuticals, Inc. The label states the product contains 30 capsules. It includes storage instructions, dispensing guidelines, and manufacturer information. The label shows the NDC 31722-571-30 and highlights that each pink and black capsule contains 30 mg of lansoprazole USP as enteric-coated pellets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.